Analgesic Preoperative/Postoperative Dexketoprofen Trometamol in Third Molar Surgery
Analgesic Efficacy of Preoperative Oral Administration of Dexketoprofen Trometamol in Third Molar Surgery, Compared to Postoperative Administration
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of the present investigation is to evaluate the effectiveness of the preoperative administration of Dexketoprofen Trometamol, employing the third molar surgery model, when compared to postoperative administration of the same drug. It was hypothesized that preoperative oral Dexketoprofen trometamol will reduce the intensity of pain by 30% after 8 hours of the surgery, when compared with post-operative administration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 postoperative-pain
Started Jan 2015
Shorter than P25 for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 22, 2015
CompletedFirst Posted
Study publicly available on registry
March 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedAugust 14, 2015
August 1, 2015
7 months
February 22, 2015
August 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain measurement employing a previous validated visual analogue scale of pain (VAS).
Postoperative pain measurement will be held every 8 hours for the next 72 hours after the surgical intervention
72 hours
Secondary Outcomes (2)
Number of patients with adverse events, to determine tolerability of the drugs.
7 days
needing of second dosage administration
72 hours
Study Arms (2)
Dexketoprofen trometamol
EXPERIMENTALA White round pill with 25 mg of dexketoprofen will be administered 30 minutes before the impacted third molar surgery start. Immediately after the surgery, a hard-gelatin capsule with placebo will be administered.
Preoperative control
PLACEBO COMPARATORA hard-gelatin capsule with placebo will be administered 30 minutes before the impacted third molar surgery start. Immediately after the surgery, a hard-gelatin capsule with 25mg of Dexketoprofen will be administered.
Interventions
White round pill containing 25mg of Dexketoprofen will be administered either prior/after to third molar surgery.
white round pill containing 25mg of placebo will be administered prior/after to third molar surgery. The placebo pill is identical to active dexketoprofen, in size and color
Eligibility Criteria
You may qualify if:
- Healthy volunteers between 18-28 years old
- Clinical and radiographic diagnosis of impacted mandibular third molars, which the surgical approach may include flap and osteotomy procedures.
- surgery classified as simple to moderate
- Voluntary acceptance of written consent, previously approved by institutional ethics committee
You may not qualify if:
- Prior administration of analgesic or anti-inflammatory drugs
- History of drug dependence
- History of allergic reactions to any of the drugs selected, or local anesthetics
- Simultaneous presence of oral pathologies that may interfere with the surgical procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FACULTY OF MEDICINE, San Luis Potosi University
San Luis Potosí City, San Luis Potosí, 78290, Mexico
Related Publications (36)
Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol. 2010;617:175-90. doi: 10.1007/978-1-60327-323-7_15.
PMID: 20336423BACKGROUNDMarciani RD. Third molar removal: an overview of indications, imaging, evaluation, and assessment of risk. Oral Maxillofac Surg Clin North Am. 2007 Feb;19(1):1-13, v. doi: 10.1016/j.coms.2006.11.007.
PMID: 18088860BACKGROUNDSeymour RA, Meechan JG, Blair GS. An investigation into post-operative pain after third molar surgery under local analgesia. Br J Oral Maxillofac Surg. 1985 Dec;23(6):410-8. doi: 10.1016/0266-4356(85)90025-7.
PMID: 2933061BACKGROUNDPozos AJ, Martinez R, Aguirre P, Perez J. Tramadol administered in a combination of routes for reducing pain after removal of an impacted mandibular third molar. J Oral Maxillofac Surg. 2007 Aug;65(8):1633-9. doi: 10.1016/j.joms.2006.06.267. No abstract available.
PMID: 17656294BACKGROUNDIsiordia-Espinoza MA, Pozos-Guillen AJ, Martinez-Rider R, Herrera-Abarca JE, Perez-Urizar J. Preemptive analgesic effectiveness of oral ketorolac plus local tramadol after impacted mandibular third molar surgery. Med Oral Patol Oral Cir Bucal. 2011 Sep 1;16(6):e776-80. doi: 10.4317/medoral.16854.
PMID: 21217614BACKGROUNDWilliamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.
PMID: 16000093BACKGROUNDBreivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A. Assessment of pain. Br J Anaesth. 2008 Jul;101(1):17-24. doi: 10.1093/bja/aen103. Epub 2008 May 16.
PMID: 18487245BACKGROUNDBarden J, Edwards JE, McQuay HJ, Wiffen PJ, Moore RA. Relative efficacy of oral analgesics after third molar extraction. Br Dent J. 2004 Oct 9;197(7):407-11; discussion 397. doi: 10.1038/sj.bdj.4811721.
PMID: 15475903BACKGROUNDGajraj NM, Joshi GP. Role of cyclooxygenase-2 inhibitors in postoperative pain management. Anesthesiol Clin North Am. 2005 Mar;23(1):49-72. doi: 10.1016/j.atc.2004.11.011.
PMID: 15763411BACKGROUNDCoxib and traditional NSAID Trialists' (CNT) Collaboration; Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.
PMID: 23726390BACKGROUNDHawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):801-20. doi: 10.1053/bega.2001.0236.
PMID: 11566042BACKGROUNDJin F, Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth. 2001 Nov;13(7):524-39. doi: 10.1016/s0952-8180(01)00320-8.
PMID: 11704453BACKGROUNDRodriguez MJ, Arbos RM, Amaro SR. Dexketoprofen trometamol: clinical evidence supporting its role as a painkiller. Expert Rev Neurother. 2008 Nov;8(11):1625-40. doi: 10.1586/14737175.8.11.1625.
PMID: 18986233BACKGROUNDVeys EM. 20 years' experience with ketoprofen. Scand J Rheumatol Suppl. 1991;90:Suppl 1-44.
PMID: 1947892BACKGROUNDMauleon D, Artigas R, Garcia ML, Carganico G. Preclinical and clinical development of dexketoprofen. Drugs. 1996;52 Suppl 5:24-45; discussion 45-6. doi: 10.2165/00003495-199600525-00005.
PMID: 8922555BACKGROUNDBarbanoj MJ, Antonijoan RM, Gich I. Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet. 2001;40(4):245-62. doi: 10.2165/00003088-200140040-00002.
PMID: 11368291BACKGROUNDKatz J, Clarke H, Seltzer Z. Review article: Preventive analgesia: quo vadimus? Anesth Analg. 2011 Nov;113(5):1242-53. doi: 10.1213/ANE.0b013e31822c9a59. Epub 2011 Sep 30.
PMID: 21965352BACKGROUNDSavage MG, Henry MA. Preoperative nonsteroidal anti-inflammatory agents: review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Aug;98(2):146-52. doi: 10.1016/j.tripleo.2004.01.012.
PMID: 15316540BACKGROUNDJoshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North Am. 2005 Mar;23(1):21-36. doi: 10.1016/j.atc.2004.11.013.
PMID: 15763409BACKGROUNDKelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth. 2001 Nov;48(10):1000-10. doi: 10.1007/BF03016591.
PMID: 11698320BACKGROUNDMoiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology. 2002 Mar;96(3):725-41. doi: 10.1097/00000542-200203000-00032. No abstract available.
PMID: 11873051BACKGROUNDWoolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993 Aug;77(2):362-79. doi: 10.1213/00000539-199377020-00026. No abstract available.
PMID: 8346839BACKGROUNDKissin I. Preemptive analgesia. Anesthesiology. 2000 Oct;93(4):1138-43. doi: 10.1097/00000542-200010000-00040. No abstract available.
PMID: 11020772BACKGROUNDDahl JB, Moiniche S. Pre-emptive analgesia. Br Med Bull. 2004 Dec 13;71:13-27. doi: 10.1093/bmb/ldh030. Print 2004.
PMID: 15596866BACKGROUNDBrennan TJ, Kehlet H. Preventive analgesia to reduce wound hyperalgesia and persistent postsurgical pain: not an easy path. Anesthesiology. 2005 Oct;103(4):681-3. doi: 10.1097/00000542-200510000-00004. No abstract available.
PMID: 16192759BACKGROUNDKissin I. Preemptive analgesia at the crossroad. Anesth Analg. 2005 Mar;100(3):754-756. doi: 10.1213/01.ANE.0000144429.39988.9B. No abstract available.
PMID: 15728065BACKGROUNDKehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. doi: 10.1016/S0140-6736(06)68700-X.
PMID: 16698416BACKGROUNDKehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. doi: 10.1016/s0002-9610(02)00866-8.
PMID: 12095591BACKGROUNDVadivelu N, Mitra S, Schermer E, Kodumudi V, Kaye AD, Urman RD. Preventive analgesia for postoperative pain control: a broader concept. Local Reg Anesth. 2014 May 29;7:17-22. doi: 10.2147/LRA.S62160. eCollection 2014.
PMID: 24872720BACKGROUNDSagiroglu G. Comparing early postoperative period analgesic effect of dexketoprofene trometamol and lornoxicam in mediastinoscopy cases. Eurasian J Med. 2011 Apr;43(1):23-6. doi: 10.5152/eajm.2011.05.
PMID: 25610155BACKGROUNDKara I, Tuncer S, Erol A, Reisli R. [The effects of preemptive dexketoprofen use on postoperative pain relief and tramadol consumption]. Agri. 2011 Jan;23(1):18-21. doi: 10.5505/agri.2011.21939. Turkish.
PMID: 21341148BACKGROUNDKesimci E, Gumus T, Izdes S, Sen P, Kanbak O. Comparison of efficacy of dexketoprofen versus paracetamol on postoperative pain and morphine consumption in laminectomy patients. Agri. 2011 Oct;23(4):153-9. doi: 10.5505/agri.2011.86548.
PMID: 22290679BACKGROUNDCagiran E, Eyigor C, Sezer B, Uyar M. Preemptive analgesic efficacy of dexketoprofen trometamol on impacted third molar surgery. Agri. 2014;26(1):29-33. doi: 10.5505/agri.2014.55265.
PMID: 24481581BACKGROUNDPeduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 Dec;49(12):1373-9. doi: 10.1016/s0895-4356(96)00236-3.
PMID: 8970487BACKGROUNDJuodzbalys G, Daugela P. Mandibular third molar impaction: review of literature and a proposal of a classification. J Oral Maxillofac Res. 2013 Jul 1;4(2):e1. doi: 10.5037/jomr.2013.4201.
PMID: 24422029BACKGROUNDEsparza-Villalpando V, Chavarria-Bolanos D, Gordillo-Moscoso A, Masuoka-Ito D, Martinez-Rider R, Isiordia-Espinoza M, Pozos-Guillen A. Comparison of the analgesic efficacy of preoperative/postoperative oral dexketoprofen trometamol in third molar surgery: A randomized clinical trial. J Craniomaxillofac Surg. 2016 Sep;44(9):1350-5. doi: 10.1016/j.jcms.2016.06.002. Epub 2016 Jun 9.
PMID: 27378000DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Amaury Pozos, PhD
Universidad Autonoma de San Luis Potosí
- PRINCIPAL INVESTIGATOR
Vicente Esparza, Resident
Universidad Autonoma de San Luis Potosí
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. Daniel Chavarría Bolaños, MSc. PhD
Study Record Dates
First Submitted
February 22, 2015
First Posted
March 5, 2015
Study Start
January 1, 2015
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
August 14, 2015
Record last verified: 2015-08